Familial Non-Toxic Hyperthyroxinaemia: Receptor or 5′-Deiodinase Defect or Deficiency

Lalloz MRA Byfield PGH Goel KM Loudon MM Thomson JA Himsworth RL . Hyperthyroxinaemia due to the coexistence of two raised affinity thyroxinebinding proteins (albumin and prealbumin) in one family. J Clin Endocrinol Metab 1987; 64: 346–52.

Sakata S Nakamura S Miura K. Autoantibodies against thyroid hormones or iodothyronine. Ann Intern Med 1985; 103: 579–89.

Wenzel KW . Pharmacological interference with in vitro tests of thyroid function. Metabolism 1981; 30: 717–32.

Rajatanavin R Braverman LE . Euthyroid hyperthyroxinemia. J Endocrinol Invest 1983; 6: 493–505.

Smallridge RC . Thyrotropin-secreting pituitary tumours. Endocrinol Metab Clin North Am 1987; 16: 765–92.

Sakurai A Takeda K Ain K Generalised resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor β. Proc Natl Acad Sci USA 1989; 86: 8977–81.

Faglia G Beck-Peccoz P Piscitelli G Medri G. Inappropriate secretion of thyrotropin by the pituitary. Hormone Res 1987; 26: 79–99.

Hirsch HJ Shilo S Spitz IM . Evolution of hypothyroidism in familial goitre due to deiodinase deficiency: Report of a family and review of the literature. Postgrad Med J 1986; 62: 477–80.

Anniko M Backlund E-O Lundquist P-G Pituitary tumor producing only thyrotropin: A case report. ORL J Otorhinolaryngol Relat Spec 1982; 44: 134–41.

Refetoff S DeGroot L Benard B DeWind LT . Studies of a sibship with apparent hereditary resistance to the intracellular action of thyroid hormone. Metabolism 1972; 21: 723–56.

Refetoff S. Syndromes of thyroid hormone resistance. Am J Physiol 1982; 243: E88–E98.

Kleinhaus N Faber J Kahana L Schneer J Scheinfeld M. Euthyroid hyperthyroxinemia due to a generalised 5′-deiodinase defect. J Clin Endocrinol Metab 1988; 66: 684–8.

Faber J Kirkegaard C Lumholtz IB Siersbaek-Nielsen KAJ Friis K. Measurement of serum 3′,5′-diiodothyronine and 3,3′-diiodothyronine concentrations in normal subjects and in patients with thyroid and nonthyroid disease: Studies of 3′,5′-diiodothyronine metabolism. J Clin Endocrinol Metab 1979; 48: 611–17.

Griffiths RS Black EG Hoffenberg R. Measurement of serum 3,3′5′ (reverse)-T₃ with comments on its derivation. Clin Endocrinol 1976; 5: 679–85.

Laurell C-B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Analyt Biochem 1966; 15: 45–52.

Iqbal MJ Johnson MW . Study of steroid-protein binding by a novel ‘two-tier’ column employing cibacron blue F3G-A-Sepharose 4B. 1-Sex hormone binding globulin. J Steroid Biochem 1977; 8: 977–83.

Sarne DH Refetoff S Rosenfield RL Farriaux JP . Sex hormone-binding globulin in the diagnosis of peripheral tissue resistance to thyroid hormone: The value of changes after short term triiodothyronine administration. J Clin Endocrinol Metab 1988; 66: 740–6.

Pagliara AS Caplan RH Gundersen CB Wickus GG Elston ACV . Peripheral resistance to thyroid hormone in a family: Heterogeneity of clinical presentation. J Pediatr 1983; 103: 228–32.